CYP2A13 antibody (AA 252-354)
Quick Overview for CYP2A13 antibody (AA 252-354) (ABIN7149222)
Target
See all CYP2A13 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 252-354
-
Cross-Reactivity
- Human, Mouse
-
Purification
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Cytochrome P450 2A13 protein (252-354aa)
-
Isotype
- IgG
-
-
-
-
Application Notes
- Recommended dilution: WB:1:1000-1:5000, IHC:1:100-1:500,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- CYP2A13 (Cytochrome P450, Family 2, Subfamily A, Polypeptide 13 (CYP2A13))
-
Alternative Name
- CYP2A13
-
Background
-
Background: Exhibits a coumarin 7-hydroxylase activity. Active in the metabolic activation of hexamethylphosphoramide, N,N-dimethylaniline, 2'-methoxyacetophenone, N-nitrosomethylphenylamine, and the tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Possesses phenacetin O-deethylation activity.
Aliases: Cytochrome P450 2A13 (EC 1.14.14.1) (CYPIIA13), CYP2A13
-
UniProt
- Q16696
Target
-